Traws Historical Balance Sheet

TRAW Stock

8.67 0.21 2.36%

Trend analysis of Traws Pharma balance sheet accounts such as Property Plant And Equipment Net of 29.8 K, Current Deferred Revenue of 180.8 K, Accounts Payable of 4.7 M or Cash of 34.4 M provides information on Traws Pharma's total assets, liabilities, and equity, which is the actual value of Traws Pharma to its prevalent stockholders. By breaking down trends over time using Traws Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Traws Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Traws Pharma is a good buy for the upcoming year.

Traws Pharma Inventory

1.71 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

About Traws Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Traws Pharma at a specified time, usually calculated after every quarter, six months, or one year. Traws Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Traws Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Traws currently owns. An asset can also be divided into two categories, current and non-current.

Traws Pharma Balance Sheet Chart

At this time, Traws Pharma's Total Current Assets are fairly stable compared to the past year. Common Stock is likely to climb to about 298.2 K in 2025, whereas Net Debt is likely to drop (19.7 M) in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of Traws Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Traws Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Traws Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Traws Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Traws Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Total Current Assets are fairly stable compared to the past year. Common Stock is likely to climb to about 298.2 K in 2025, whereas Net Debt is likely to drop (19.7 M) in 2025.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	4.0M	3.4M	3.0M	3.1M
Total Assets	39.4M	22.7M	26.1M	35.5M

Other Current Liab Total Assets

Traws Pharma balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Inventory	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock
Total Assets		-0.47	-0.81	1.0	-0.42	-0.21	-0.91	-0.49	-0.54	1.0	-0.62	-0.64	-0.21	1.0	-0.51	0.5	-0.44	-0.06	0.49	-0.82	1.0	-0.5	-0.05	0.98	-0.01	0.6
Other Current Liab	-0.47		0.71	-0.46	0.58	0.54	0.23	0.34	-0.14	-0.44	0.62	0.62	0.54	-0.44	0.34	-0.38	0.64	-0.55	-0.59	0.83	-0.47	0.18	-0.56	-0.4	-0.59	-0.65
Total Current Liabilities	-0.81	0.71		-0.81	0.21	0.42	0.63	0.14	0.51	-0.81	0.4	0.42	0.42	-0.81	0.18	-0.15	0.3	-0.03	-0.3	0.91	-0.81	0.08	-0.05	-0.7	0.0	-0.38
Total Stockholder Equity	1.0	-0.46	-0.81		-0.39	-0.15	-0.93	-0.46	-0.58	1.0	-0.58	-0.61	-0.15	1.0	-0.47	0.46	-0.4	-0.11	0.44	-0.81	1.0	-0.46	-0.09	0.98	-0.05	0.56
Property Plant And Equipment Net	-0.42	0.58	0.21	-0.39		0.51	0.2	0.87	-0.46	-0.39	0.96	0.95	0.51	-0.39	0.86	-0.93	0.97	-0.72	-0.93	0.59	-0.43	0.78	-0.73	-0.48	-0.78	-0.96
Current Deferred Revenue	-0.21	0.54	0.42	-0.15	0.51		-0.22	0.38	-0.4	-0.19	0.56	0.54	1.0	-0.19	0.54	-0.45	0.68	-0.81	-0.64	0.63	-0.21	0.41	-0.81	-0.13	-0.63	-0.55
Net Debt	-0.91	0.23	0.63	-0.93	0.2	-0.22		0.31	0.71	-0.91	0.37	0.41	-0.22	-0.91	0.28	-0.31	0.14	0.42	-0.22	0.55	-0.91	0.32	0.4	-0.92	0.27	-0.36
Retained Earnings	-0.49	0.34	0.14	-0.46	0.87	0.38	0.31		-0.24	-0.46	0.91	0.91	0.38	-0.46	0.92	-0.91	0.85	-0.57	-0.79	0.48	-0.49	0.88	-0.58	-0.58	-0.52	-0.85
Accounts Payable	-0.54	-0.14	0.51	-0.58	-0.46	-0.4	0.71	-0.24		-0.57	-0.27	-0.24	-0.4	-0.57	-0.34	0.38	-0.48	0.78	0.46	0.19	-0.54	-0.29	0.78	-0.49	0.83	0.33
Cash	1.0	-0.44	-0.81	1.0	-0.39	-0.19	-0.91	-0.46	-0.57		-0.59	-0.62	-0.19	1.0	-0.49	0.47	-0.41	-0.1	0.46	-0.81	1.0	-0.48	-0.08	0.98	-0.04	0.57
Non Current Assets Total	-0.62	0.62	0.4	-0.58	0.96	0.56	0.37	0.91	-0.27	-0.59		1.0	0.56	-0.59	0.91	-0.94	0.97	-0.66	-0.94	0.73	-0.62	0.84	-0.67	-0.66	-0.68	-0.99
Non Currrent Assets Other	-0.64	0.62	0.42	-0.61	0.95	0.54	0.41	0.91	-0.24	-0.62	1.0		0.54	-0.62	0.91	-0.94	0.96	-0.63	-0.94	0.74	-0.65	0.84	-0.64	-0.69	-0.66	-0.99
Other Assets	-0.21	0.54	0.42	-0.15	0.51	1.0	-0.22	0.38	-0.4	-0.19	0.56	0.54		-0.19	0.54	-0.45	0.68	-0.81	-0.64	0.63	-0.21	0.41	-0.81	-0.13	-0.63	-0.55
Cash And Short Term Investments	1.0	-0.44	-0.81	1.0	-0.39	-0.19	-0.91	-0.46	-0.57	1.0	-0.59	-0.62	-0.19		-0.49	0.47	-0.41	-0.1	0.46	-0.81	1.0	-0.48	-0.08	0.98	-0.04	0.57
Net Receivables	-0.51	0.34	0.18	-0.47	0.86	0.54	0.28	0.92	-0.34	-0.49	0.91	0.91	0.54	-0.49		-0.97	0.9	-0.64	-0.91	0.53	-0.52	0.98	-0.64	-0.59	-0.65	-0.9
Common Stock Shares Outstanding	0.5	-0.38	-0.15	0.46	-0.93	-0.45	-0.31	-0.91	0.38	0.47	-0.94	-0.94	-0.45	0.47	-0.97		-0.92	0.62	0.94	-0.52	0.51	-0.95	0.62	0.59	0.7	0.95
Non Current Liabilities Total	-0.44	0.64	0.3	-0.4	0.97	0.68	0.14	0.85	-0.48	-0.41	0.97	0.96	0.68	-0.41	0.9	-0.92		-0.81	-0.97	0.67	-0.45	0.8	-0.83	-0.47	-0.83	-0.97
Other Current Assets	-0.06	-0.55	-0.03	-0.11	-0.72	-0.81	0.42	-0.57	0.78	-0.1	-0.66	-0.63	-0.81	-0.1	-0.64	0.62	-0.81		0.74	-0.38	-0.06	-0.52	1.0	-0.06	0.9	0.66
Other Stockholder Equity	0.49	-0.59	-0.3	0.44	-0.93	-0.64	-0.22	-0.79	0.46	0.46	-0.94	-0.94	-0.64	0.46	-0.91	0.94	-0.97	0.74		-0.66	0.5	-0.85	0.75	0.53	0.84	0.97
Total Liab	-0.82	0.83	0.91	-0.81	0.59	0.63	0.55	0.48	0.19	-0.81	0.73	0.74	0.63	-0.81	0.53	-0.52	0.67	-0.38	-0.66		-0.83	0.42	-0.4	-0.75	-0.36	-0.72
Total Current Assets	1.0	-0.47	-0.81	1.0	-0.43	-0.21	-0.91	-0.49	-0.54	1.0	-0.62	-0.65	-0.21	1.0	-0.52	0.51	-0.45	-0.06	0.5	-0.83		-0.51	-0.04	0.98	0.0	0.6
Common Stock	-0.5	0.18	0.08	-0.46	0.78	0.41	0.32	0.88	-0.29	-0.48	0.84	0.84	0.41	-0.48	0.98	-0.95	0.8	-0.52	-0.85	0.42	-0.51		-0.52	-0.6	-0.55	-0.83
Inventory	-0.05	-0.56	-0.05	-0.09	-0.73	-0.81	0.4	-0.58	0.78	-0.08	-0.67	-0.64	-0.81	-0.08	-0.64	0.62	-0.83	1.0	0.75	-0.4	-0.04	-0.52		-0.04	0.9	0.67
Net Invested Capital	0.98	-0.4	-0.7	0.98	-0.48	-0.13	-0.92	-0.58	-0.49	0.98	-0.66	-0.69	-0.13	0.98	-0.59	0.59	-0.47	-0.06	0.53	-0.75	0.98	-0.6	-0.04		0.02	0.64
Property Plant And Equipment Gross	-0.01	-0.59	0.0	-0.05	-0.78	-0.63	0.27	-0.52	0.83	-0.04	-0.68	-0.66	-0.63	-0.04	-0.65	0.7	-0.83	0.9	0.84	-0.36	0.0	-0.55	0.9	0.02		0.75
Capital Stock	0.6	-0.65	-0.38	0.56	-0.96	-0.55	-0.36	-0.85	0.33	0.57	-0.99	-0.99	-0.55	0.57	-0.9	0.95	-0.97	0.66	0.97	-0.72	0.6	-0.83	0.67	0.64	0.75

Click cells to compare fundamentals

Traws Pharma Account Relationship Matchups

Traws Pharma balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	20.0M	55.5M	39.4M	22.7M	26.1M	35.5M
Other Current Liab	5.0M	3.1M	4.0M	3.4M	3.0M	3.1M
Total Current Liabilities	10.0M	6.1M	8.0M	9.2M	8.3M	6.7M
Total Stockholder Equity	6.2M	46.1M	28.3M	10.7M	12.3M	22.6M
Property Plant And Equipment Net	52K	38K	24K	22K	19.8K	29.8K
Net Debt	(19.0M)	(55.1M)	(38.8M)	(20.8M)	(18.7M)	(19.7M)
Retained Earnings	(428.6M)	(444.7M)	(463.7M)	(482.6M)	(434.4M)	(456.1M)
Accounts Payable	4.8M	2.8M	3.9M	5.6M	6.5M	4.7M
Cash	19.0M	55.1M	38.8M	20.8M	23.9M	34.4M
Non Current Assets Total	202K	48K	25K	23K	20.7K	19.7K
Cash And Short Term Investments	19.0M	55.1M	38.8M	20.8M	23.9M	34.4M
Net Receivables	37K	28K	29K	18K	16.2K	15.4K
Common Stock Shares Outstanding	11.6M	16.8M	20.9M	21.0M	24.1M	15.7M
Liabilities And Stockholders Equity	20.0M	55.5M	39.4M	22.7M	26.1M	35.5M
Non Current Liabilities Total	3.8M	3.2M	3.0M	2.8M	2.5M	2.7M
Other Current Assets	722K	332K	561K	1.8M	2.1M	2.2M
Other Stockholder Equity	434.6M	490.6M	491.8M	493.1M	567.1M	511.3M
Total Liab	13.8M	9.4M	11.1M	12.0M	10.8M	9.3M
Total Current Assets	19.8M	55.4M	39.3M	22.7M	26.1M	35.4M
Accumulated Other Comprehensive Income	14K	(14K)	(33K)	(23K)	(20.7K)	(21.7K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

S	SentinelOne
CRM	Salesforce
MSFT	Microsoft

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Traws Historical Balance Sheet

Traws Pharma Inventory

1.71 Million

About Traws Balance Sheet Analysis

Traws Pharma Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Traws Pharma balance sheet Correlations

Traws Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Traws Pharma balance sheet Accounts

Also Currently Popular

Additional Tools for Traws Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Capital Stock	- 0.99	Non Currrent Assets Other
Capital Stock	- 0.99	Non Current Assets Total
Capital Stock	- 0.97	Non Current Liabilities Total
Other Stockholder Equity	- 0.97	Non Current Liabilities Total
Common Stock Shares Outstanding	- 0.97	Net Receivables
Capital Stock	- 0.96	Property Plant And Equipment Net